Online citations, reference lists, and bibliographies.
← Back to Search

Experimental Human Muscle Pain And Muscular Hyperalgesia Induced By Combinations Of Serotonin And Bradykinin

V. Babenko, T. Graven-Nielsen, P. Svensson, A. Drewes, L. Arendt-Nielsen
Published 1999 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In the present study, we assessed the muscle pain and possible development of muscular hyperalgesia to mechanical stimuli after two subsequent intramuscular infusions of serotonin (5-HT) and bradykinin (BKN). The pain intensity after the infusions was continuously scored on a visual analogue scale (VAS). The subjects drew the distribution of the pain areas on a map. Pressure pain thresholds (PPTs) and suprapressure pain thresholds (SPPTs) stimulations as 150% of the pre-infusion PPTs were assessed with a pressure algometer at the injection site (10 cm below the patella), at the ankle, and at the contralateral leg and ankle. Skin sensibility was assessed with a Von Frey hair at the same sites. This was done before and after an infusion into the tibialis anterior (TA) muscle on the right leg in ten volunteers. The first infusion in each combination was either serotonin (20 nmol) or isotonic saline (NaCl 0.9%). The second infusion was bradykinin (5 or 10 nmol) or isotonic saline. The two infusions were given over 20 s and separated by 3 min. The isotonic saline followed by BKN did not induce muscle pain or muscular hyperalgesia. However, the combination of 5-HT and BKN (10 nmol) produced: (1) significantly higher VAS scores (P < 0.05) compared with all other combinations; (2) significantly longer pain offset (P < 0.05) compared with the combinations of isotonic saline and BKN; (3) significantly lower PPTs at 5, 20, and 40 min post-infusion (P < 0.05) compared with baseline PPT and PPTs after all other combinations. Cutaneous sensibility to mechanical stimuli and SPPTs were not affected by any of the combinations. The combinations of serotonin and bradykinin produce experimental muscle pain and muscular hyperalgesia to mechanical stimuli. Pre-treatment with serotonin may enhance the effect of bradykinin in the generation of muscle pain and muscular hyperalgesia in humans.
This paper references
10.1016/0196-9781(89)90006-5
Algesia and local responses induced by neurokinin A and substance P in human skin and temporal muscle
U. Pedersen-Bjergaard (1989)
10.1046/j.1468-2982.1991.1104175.x
Pain, Tenderness, Wheal and Flare Induced by Substance-P, Bradykinin and 5-Hydroxytryptamine in Humans
K. Jensen (1991)
10.1016/0196-9781(90)90141-Q
Pain and tenderness in human temporal muscle induced by bradykinin and 5-hydroxytryptamine
K. Jensen (1990)
10.2337/diab.45.1.S34
Kininase II-Type Enzymes: Their Putative Role in Muscle Energy Metabolism
T. Dragović (1996)
10.1016/0304-3959(95)00239-1
Qualitatively altered nociception in chronic myofascial pain
L. Bendtsen (1996)
Desensitization of bradykinin-induced activation of peripheral nociceptors.
A. Dray (1992)
10.1097/00002508-199103001-00004
Myofascial pain syndromes: clinical and pathophysiological aspects.
L. Vecchiet (1991)
10.1016/0006-8993(88)90487-8
Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia
Y. O. Taiwo (1988)
10.1113/jphysiol.1977.sp011802
Nervous outflow from skeletal muscle following chemical noxious stimulation
S. Mense (1977)
10.1016/0006-8993(81)90320-6
Sensitization of group IV muscle receptors to bradykinin by 5-hydroxytryptamine and prostaglandin E2
S. Mense (1981)
10.1152/JN.1993.70.2.512
Contribution of edema to the sensitization of high-threshold mechanoreceptors of the goat palatal mucosa.
B. Cooper (1993)
10.1113/jphysiol.1957.sp005715
Pain‐producing substance in human inflammatory exudates and plasma
D. Armstrong (1957)
10.1038/clpt.1991.212
Pain and hyperalgesia after intradermal injection of bradykinin in humans
D. C. Manning (1991)
10.1016/0304-3959(90)92570-G
Pain and inflammation
H. Handwerker (1990)
10.1016/S0304-3959(96)03276-9
Myositis-induced functional reorganisation of the rat dorsal horn: effects of spinal superfusion with antagonists to neurokinin and glutamate receptors
U. Hoheisel (1997)
10.1016/0304-3959(93)90027-M
Nociception from skeletal muscle in relation to clinical muscle pain
S. Mense (1993)
10.1016/0006-8993(76)90593-X
Excitatory effects of 5-hydroxytryptamine, histamine and potassium ions on muscular group IV afferent units: A comparison with bradykinin
Sibylle Fock (1976)
10.1007/PL00004984
Involvement of 5-hydroxytryptamine and bradykinin in the hyperalgesia induced in rats by collagenase from clostridium histolyticum
J. Damas (1997)
10.1523/JNEUROSCI.13-06-02273.1993
Peptides and the primary afferent nociceptor
J. Levine (1993)
10.1016/0304-3959(93)90161-H
Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence
T. J. Coderre (1993)
10.1016/0304-3959(86)90235-6
Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer
K. Jensen (1986)
10.1080/08990229870943
Quantification of deep and superficial sensibility in saline-induced muscle pain--a psychophysical study.
T. Graven-Nielsen (1998)
Effect of chronic and experimental jaw muscle pain on pain-pressure thresholds and stimulus-response curves.
P. Svensson (1995)
10.1016/0304-3940(93)90064-R
Appearance of new receptive fields in rat dorsal horn neurons following noxious stimulation of skeletal muscle: a model for referral of muscle pain?
U. Hoheisel (1993)
10.1016/0304-3959(87)90089-3
Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold
A. Fischer (1987)
10.1097/00002508-199306000-00002
McGill Pain Questionnaire Translated into Danish: Experimental and Clinical Findings
A. Drewes (1993)
10.1016/0306-4522(90)90265-6
Response properties and descending control of rat dorsal horn neurons with deep receptive fields
Yu Xian-Min (1990)
10.1016/S0006-8993(96)00851-7
Pain from excitation of identified muscle nociceptors in humans
P. Marchettini (1996)
10.1113/jphysiol.1988.sp017028
Bradykinin‐induced modulation of the response behaviour of different types of feline group III and IV muscle receptors.
S. Mense (1988)
10.1139/Y97-068
Kinins and their receptors in hyperalgesia.
A. Dray (1997)
10.1038/clpt.1990.132
Glucocorticoids suppress levels of immunoreactive bradykinin in inflamed tissue as evaluated by microdialysis probes
K. M. Hargreaves (1990)
10.1093/ACPROF:OSO/9780198523345.003.0013
Sensitization of polymodal receptors
Kumazawa Takao (1996)
10.3233/BMR-1997-8209
Algometry in the daily practice of pain management.
A. Fischer (1997)
10.1016/0304-3959(92)90124-T
Hyperalgesia and expanded receptive fields
R. Dubner (1992)
Hyperexcitability in fibromyalgia.
J. Sörensen (1998)
10.1038/323158A0
Noradrenaline hyperalgesia is mediated through interaction with sympathetic postgahglionic neurone terminals rather than activation of primary afferent nociceptors
J. Levine (1986)
10.1053/eujp.1998.0103
Experimental human muscle pain induced by intramuscular injections of bradykinin, serotonin, and substance P
Vladimir Babenko (1999)



This paper is referenced by
10.1016/J.BRAINRESREV.2004.07.005
The organization of motor responses to noxious stimuli
R. Clarke (2004)
10.1038/SJ.BDJ.4801098
Facial pain: Chronic idiopathic orofacial pain: II. What can the general dental practitioner do?
T. Newton-John (2001)
10.1067/MEN.2003.68
Reducing pediatric pain during ED procedures with a nurse-driven protocol: an urban pediatric emergency department's experience.
J. Meunier-Sham (2003)
10.24377/LJMU.T.00010325
The Physiological and Genetic Factors Underpinning the Response to Muscle Damaging Exercise
P. Baumert (2019)
10.1002/cbf.1611
Effects of supplementation with free glutamine and the dipeptide alanyl‐glutamine on parameters of muscle damage and inflammation in rats submitted to prolonged exercise
V. Cruzat (2010)
10.1016/B978-84-9022-387-1.00001-2
1 – Conceptos básicos de los puntos gatillo (PG) miofasciales
César Fernández-de-las-Peñas (2013)
10.2147/JPR.S247472
Nerve Growth Factor Signaling and Its Contribution to Pain
Philip A. Barker (2020)
10.1016/j.jpain.2009.04.017
Bilateral widespread mechanical pain sensitivity in women with myofascial temporomandibular disorder: evidence of impairment in central nociceptive processing.
C. Fernández-de-las-Peñas (2009)
10.1053/eujp.2001.0230
The spatial organization of central sensitization of hind limb flexor reflexes in the decerebrated, spinalized rabbit
R. Clarke (2001)
10.1016/j.ejpain.2007.03.009
Biochemical alterations in the trapezius muscle of patients with chronic whiplash associated disorders (WAD) – A microdialysis study
B. Gerdle (2008)
10.1111/j.1468-2982.2004.00709.x
Possible Mechanisms of Pain Perception in Patients with Episodic Tension-Type Headache. A New Experimental Model of Myofascial Pain
H. Mørk (2004)
10.1016/j.pain.2004.04.033
Human and animal experimental models of acute and chronic muscle pain: intramuscular algesic injection
N. Capra (2004)
10.1097/00002508-200103000-00002
The Peripheral Apparatus of Muscle Pain: Evidence From Animal and Human Studies
T. Graven-Nielsen (2001)
10.1007/978-4-431-73242-6_12
Muscular Pain Mechanisms: Brief Review with Special Consideration of Delayed-Onset Muscle Soreness
K. Mizumura (2008)
10.1007/PL00000320
Release of algesic substances in human experimental muscle pain
I. Tegeder (2002)
Síndrome de dolor miofascial y alteraciones del procesamiento nociceptivo en pacientes con epicondilalgia lateral
Josué Fernández Carnero (2012)
10.1159/000076030
The Central Serotonergic System Mediates the Analgesic Effect of Electroacupuncture on Zusanli (ST36) Acupoints
F. Chang (2004)
10.1016/S1479-3555(01)01014-9
Psychosocial factors and musculoskeletal disorders
J. J. Hurrell (2001)
10.1054/JPAI.2002.126610
Sympathetic-independent bradykinin mechanical hyperalgesia induced by subdiaphragmatic vagotomy in the rat.
S. Khasar (2002)
10.1007/s00221-008-1674-4
Algesic agents exciting muscle nociceptors
S. Mense (2008)
10.1016/S0079-6123(00)29028-6
Modelling the prolonged effects of neonatal pain.
D. Alvares (2000)
10.1016/S0304-3959(99)00233-X
Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals
M. Ernberg (2000)
10.1007/S11926-002-0040-Y
Peripheral and central sensitization in musculoskeletal pain disorders: An experimental approach
T. Graven-Nielsen (2002)
10.1111/j.1468-2982.2007.01295.x
Myofascial Trigger Points and Sensitization: An Updated Pain Model for Tension-Type Headache
C. Fernández-de-las-Peñas (2007)
10.1007/s11916-015-0503-2
Myofascial Head Pain
C. Fernández-de-las-Peñas (2015)
10.1152/physrev.00048.2010
Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors.
G. Pethő (2012)
10.1080/10582450801960420
Sensory and Motor Manifestations of Muscle Pain
T. Graven-Nielsen (2008)
10.1097/AJP.0b013e31815b608f
Muscle Pain: Sensory Implications and Interaction With Motor Control
L. Arendt-Nielsen (2008)
Immunological changes in human blood and skeletal muscle in response to physical exercise
C. Malm (2001)
10.1093/BJA/85.4.529
Remifentanil inhibits muscular more than cutaneous pain in humans.
M. Curatolo (2000)
10.1007/s10517-005-0312-4
Analgesic Activity of 5-HT3 Receptor Antagonists
A. Spasov (2005)
10.1179/106698108790818468
Changes in Clinical Parameters in Patients with Tension-type Headache Following Massage Therapy: A Pilot Study
A. Moraska (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar